v3.25.2
Related Party Transactions (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Related Party Transactions [Line Items]          
Research and development expense   $ 5,156,988 $ 7,813 $ 14,338,055 $ 9,729,437
Accrued expense   100,000   100,000  
General and administrative expense   1,363,464 143,863 1,941,963 20,642
Prepaid expenses   636,015   834,479
Pocket expenses       200,000  
Pocket expenses       69,265
Other current liabilities   500,000      
Interest expense   50,785 42,268 191,205
Consulting fees   $ 400,000      
Incentive payment rate   50.00%      
General and administrative expense   $ 200,000      
Share-based compensation allocated percentage   30.00%      
Research and Development Expense [Member]          
Related Party Transactions [Line Items]          
Share-based compensation   $ 4,336 7,813 25,458,000,000  
General and Administrative Expense [Member]          
Related Party Transactions [Line Items]          
Share-based compensation     $ 12,608 50,434,000,000 5,428
Eil License Agreement [Member] | Promissory Note [Member]          
Related Party Transactions [Line Items]          
Aggregate principal amount   $ 1,700,000   $ 1,700,000  
Interest rate   7.00%   7.00%  
Bala License Agreement [Member] | Promissory Note [Member]          
Related Party Transactions [Line Items]          
Aggregate principal amount   $ 1,200,000   $ 1,200,000  
Interest rate   7.00%   7.00%  
Licensing Agreements [Member]          
Related Party Transactions [Line Items]          
Convenience written notice days   30 days   30 days  
After the receipt of notice period   90 days   90 days  
Legacy Lomond [Member] | Promissory Note [Member]          
Related Party Transactions [Line Items]          
Aggregate principal amount $ 7,500,000 $ 7,500,000      
Interest rate 6.00%        
Interest expense   100,000      
Abet Solutions (“Abet”) [Member]          
Related Party Transactions [Line Items]          
Research and development expense   400,000      
Eil and Bala [Member] | Promissory Note [Member]          
Related Party Transactions [Line Items]          
Interest expense   100,000      
ChemDiv, Inc. (“ChemDiv”) [Member]          
Related Party Transactions [Line Items]          
Research and development expense       $ 300,000 5,800,000
Accrued expense   200,000     900,000
Eilean Therapeutics AU Pty Ltd (“Eilean AU”) [Member]          
Related Party Transactions [Line Items]          
Research and development expense   $ 500,000   8,200,000 3,000,000
Expert Systems, Inc. (“Expert Systems”) [Member]          
Related Party Transactions [Line Items]          
Research and development expense       $ 1,300,000  
Eil Therapeutics, Inc (“Eil”) [Member]          
Related Party Transactions [Line Items]          
Research and development expense         1,000,000
Termination Loans, Description   The administrative services agreement with Eil was terminated in October 2024.   The administrative services agreement with Eil was terminated in October 2024.  
Eil Therapeutics, Inc (“Eil”) [Member] | Promissory Note [Member]          
Related Party Transactions [Line Items]          
Aggregate principal amount         $ 1,300,000
Interest rate         2.50%
Abet Solutions (“Abet”) [Member]          
Related Party Transactions [Line Items]          
Research and development expense       $ 600,000  
General and administrative expense   $ 20,000   100,000  
Prepaid expenses       200,000  
Dinas Therapeutics, Inc. (“Dinas”) [Member] | Promissory Note [Member]          
Related Party Transactions [Line Items]          
Aggregate principal amount       $ 3,900,000  
Interest rate       5.00%  
Eilean AU Research and Development [Member]          
Related Party Transactions [Line Items]          
Research and development expense   1,400,000      
Related Party [Member]          
Related Party Transactions [Line Items]          
Research and development expense   $ 200,000